US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Acetaminophen Infant Dye Free Grape Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0584-2022
Class II · Moderate risk Terminated

Acetaminophen Child Strawberry Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0583-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Suspension Grape Flavor

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0579-2022
Class III · Low risk Terminated

Topiramate Tablets

Reason Discoloration

Unichem Pharmaceuticals USA INC NDC 29300-116-05 D-0255-2022
Class II · Moderate risk Terminated

Tadalafil Tablets

Reason Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Sun Pharmaceutical Industries INC NDC 16714-077-01 D-0231-2022
Class II · Moderate risk Terminated

Tadalafil Tablets

Reason Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Sun Pharmaceutical Industries INC NDC 16714-075-01 D-0230-2022
Class II · Moderate risk Terminated

Pregabalin Capsules

Reason Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

Sun Pharmaceutical Industries INC NDC 47335-687-88 D-0361-2022
Class III · Low risk Terminated

Gatifloxacin Ophthalmic Solution

Reason Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0091-2022
Class I · High risk Terminated

Cubicin

Reason Presence of Particulate Matter: Identified as Glass Particles

Merck Sharp & Dohme CORP D-0093-2022
Class III · Low risk Terminated

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg

Reason Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Macleods Pharma USA, INC NDC 33342-093-41 D-0079-2022
Class III · Low risk Terminated

Rizatriptan Benzoate Film Coated Tablets

Reason Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Macleods Pharma USA, INC NDC 33342-088-45 D-0078-2022
Class II · Moderate risk Terminated

Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity

Golden State Medical Supply Inc. NDC 51407-193-05 D-0228-2022
Class II · Moderate risk Terminated

Ezetimibe and Simvastatin Tablets

Reason Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Golden State Medical Supply Inc. D-0227-2022
Class III · Low risk Terminated

Afassco Pain Free Plus X-STRENGTH PAIN RELIEVER

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0077-2022
Class III · Low risk Terminated

Xpect First aid Extra Strength PAIN AWAY

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0076-2022
Class III · Low risk Terminated

Advance Formula Pain Reliever

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0075-2022
Class III · Low risk Terminated

North by Honeywell PAIN STOPPER EXTRA STRENGTH

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0074-2022